CCL2 and gastric cancer: EVs from gastric cancer(GC) cells treated with MLT promote the expression of TNF-α and CXCL10 in macrophages while suppressing IL-6 and MCP-1 expression, concurrently downregulating PD-L1 protein levels [151].